CCL2 and metabolic dysfunction-associated steatohepatitis: For example, increase in serum levels of CCL2 is associated with progression from hepatic steatosis to NASH [63], and CCL2 expression is correlated with disease severity in Hepatitis C-dependent liver fibrosis [64].